Developer docs
API playgroundTry for free, no card

Search company profiles

Vidal Vademecum Spain

Full company profile

uuid0039mnl

Namestring
Vidal Vademecum Spain
Legal namestring
Vidal Vademecum Spain, S.A.
Websiteurl
vademecum.es
Company typeenum
Private
Founded yearint
1992
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical reference database, medical information publishing, healthcare professional subscriptions, drug information platform, pharma advertising medium
Industry3 codes
1Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
CodeHLACAOANPrimaryYes
2Compliance & Risk Intelligence Publishing (KYC/AML, ESG, Cyber, Privacy)
CodeMPAJACACPrimaryNo
3Healthcare/Pharma Creative Agencies
CodeMPAAAAAJPrimaryNo
NAICS code2 codes
  • Professional, Scientific, and Technical Services54
  • Advertising Agencies541810
Product category
Pharmaceutical reference / medical information publishing
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Professional Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to pharmaceutical database and professional resources for healthcare professionals including physicians, pharmacists, and other medical professionals in Spain

vademecum.es
2Pharmaceutical Advertising
TypeAdvertising
Description

Advertising and promotional content services for pharmaceutical companies targeting healthcare professionals, enabled by official recognition as valid support for prescription medicine advertising (S.V.nº09/10-W-CM)

vademecum.es
3B2B Services and Data
TypeSubscription Recurring
Description

Professional data services, authentication services (Vademecum Connect), and data partnerships with healthcare organizations and pharmaceutical companies

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Pricing details1 tier
1Professional individual and institutional subscriptions for healthcare professionals
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

vademecum.es
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 2 records shown
1VADEMECUM CONNECT
Description

Authentication solution allowing Vademecum account holders to log into third-party websites using their Vademecum credentials.

+1 more record
Core offering1 text field

Vidal Vademecum Spain publishes and operates Vademecum.es, a curated pharmaceutical reference platform providing drug information, active ingredients, ATC classifications, laboratory details, indications, international equivalences, CNIS drug information, therapeutic positioning reports, safety alerts, and supply-chain notices exclusively to qualified healthcare professionals in Spain. The platform also enables pharmaceutical companies to run regulatory-compliant advertising directed at those professionals, and offers authentication (Vademecum Connect) and education (Campus) as adjacent services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Vidal Vademecum Spain operates Vademecum.es, a comprehensive pharmaceutical reference database for healthcare professionals in Spain. The platform provides a unified system with multiple integrated modules including the core drug database (medications, active ingredients, ATC classifications, laboratories, clinical indications), CNIS drug information center, therapeutic positioning reports (IPT), safety information materials (MPR), the Campus educational platform, Vademecum Connect authentication service, and a newsletter (Boletín). The platform also includes specialized databases for supply issues (incidencias de suministro), safety alerts (alertas), and international equivalences. The offering is directed exclusively at healthcare professionals and is officially recognized by Spanish health authorities as a valid medium for prescription medication advertising.

Product and service8 records
1Vademecum.es
CategoryPharmaceutical reference platform
Description

Core web platform providing a curated Spanish pharmaceutical drug reference covering medications, active pharmaceutical ingredients, ATC classifications, laboratories, clinical indications, international equivalences, AEMPS safety alerts, and supply-incident tracking. Exclusively for verified healthcare professionals.

2Vademecum Box
CategoryReference tool
Description

Professional tool providing streamlined access to Vademecum's pharmaceutical knowledge and medication information for prescribers and pharmacists.

3Campus
CategoryProfessional education
Description

Medical education platform providing courses, webinars, and clinical training resources for healthcare professionals.

4CNIS Drug Information Center
CategoryDrug information service
Description

Drug information center within Vademecum providing detailed medication data and therapeutic positioning reports (IPT) for healthcare professionals.

5Listado IPT
CategoryRegulatory reference
Description

Curated collection of therapeutic positioning reports (Informes de Posicionamiento Terapéutico) authorized by AEMPS, providing pharmacological assessment documentation.

6Listado MPR
CategoryDrug safety materials
Description

Listing of safety information materials (Materiales Informativos sobre Seguridad) about AEMPS-authorized medications, covering risk minimization materials for HCPs.

7Vademecum Connect
CategoryIdentity and access service
Description

Federated identity / SSO service allowing healthcare professionals to securely access third-party partner healthcare websites using their existing Vademecum account credentials.

8Boletín
CategoryProfessional communications
Description

Newsletter service delivering pharmaceutical news, AEMPS drug alerts, supply updates, and clinical information to registered healthcare professionals.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Content providers supplying medication information, product details, and promotional content. Pharmaceutical companies are responsible for the accuracy of their submitted information per pharmaceutical regulations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partners in sending non-promotional health information. Joint data controllers for communications to healthcare professionals about partner products and services.

3Third-party Healthcare Websites (Vademecum Connect)
Strategic tierSupportingTypeTechnology or Integration
Description

Healthcare websites implementing Vademecum Connect authentication allowing professionals to use their Vademecum credentials for access. User data transferred to third-party site operators as independent data controllers.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Advertising partners using personalized advertising cookies and tracking technologies. Partners operate under IAB Transparency and Consent Framework 2.0 for consent management.

Strategic tierCoreTypeOthers
Description

Official regulatory body. Vademecum.es aggregates and distributes AEMPS alerts, safety notices, supply issue reports, and therapeutic positioning information for healthcare professionals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major professional medical information and education platform with pharma advertising and reference tools. Comparable in combining HCP drug reference, professional education, and pharma sponsorship, but operates at much larger scale and global scope.

TypeDirect peer
Description

Online pharmaceutical reference providing drug information, interactions, and consumer/professional tools. Closely comparable as a multi-revenue (ads + data) drug information platform serving HCPs and consumers, though with a US/global orientation.

TypeDirect peer
Description

Provider of drug knowledge and medication decision support used by EHRs, pharmacies, and HCPs. Comparable as a B2B drug information and data services company monetizing professional subscribers and enterprise integrations.

TypeBroad incumbent
Description

Ultimate parent company of Vidal Vademecum Spain, operating a global medical information, physician platform, and marketing services business (including MDLinx and m3.com). Comparable at the business model and category level (HCP drug information, pharma marketing) though far larger and diversified.

5CIMA (AEMPS - Centro de Información online de Medicamentos de la AEMPS)
TypeRegional player
Description

Official Spanish regulator's drug information portal. Comparable in covering Spanish-approved medicines, drug data, and IPTs, but as a free government-issued source that can substitute for parts of Vademecum's offering.

TypeBroad incumbent
Description

Large incumbent publisher of clinical drug information and decision support tools. Overlaps with Vademecum's professional drug reference and clinical decision support offering, but as part of a much broader portfolio.

TypeBroad incumbent
Description

Elsevier's clinical and drug information platforms serve HCPs with reference, drug, and regulatory content. Comparable in combining curated pharmaceutical content with professional subscription models, embedded in a large publishing incumbent.

TypeDirect peer
Description

Direct sister brand of Vidal Vademecum Spain under the same Vidal Group (controlled by M3, Inc.). Operates the same drug information reference platform model for healthcare professionals in France, making it the most structurally comparable peer.

9Bot Plus (Consejo General de Colegios Farmacéuticos)
TypeRegional player
Description

Official Spanish pharmacy drug database operated by the General Council of Pharmacists. Comparable as a Spanish HCP drug reference, but free and pharmacy-society-issued, representing a regulated substitute rather than a commercial competitor.

TypeDirect peer
Description

Clinical decision support and drug information solution used by hospitals and HCPs. Comparable as a paid, professional-grade drug reference and evidence database with subscription and enterprise models.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vidal Vademecum Spain

Pharmaceutical reference / medical information publishingvademecum.es

Vidal Vademecum Spain firmographics

Firmographics
Name
Vidal Vademecum Spain
Legal name
Vidal Vademecum Spain, S.A.
Website
https://vademecum.es
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Vidal Vademecum Spain industry classification

Industry
Product category
Pharmaceutical reference / medical information publishing
NAICS
Professional, Scientific, and Technical Services (54), Advertising Agencies (541810)
akta.pro primary industry
Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN)
akta.pro secondary industries
Compliance & Risk Intelligence Publishing (KYC/AML, ESG, Cyber, Privacy) (MPAJACAC), Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

  • Pharmaceutical reference database
  • Medical information publishing
  • Healthcare professional subscriptions
  • Drug information platform
  • Pharma advertising medium

Where Vidal Vademecum Spain is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Vidal Vademecum Spain business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Professional Subscriptions: Subscription-based access to pharmaceutical database and professional resources for healthcare professionals including physicians, pharmacists, and other medical professionals in Spain
  2. Pharmaceutical Advertising: Advertising and promotional content services for pharmaceutical companies targeting healthcare professionals, enabled by official recognition as valid support for prescription medicine advertising (S.V.nº09/10-W-CM)
  3. B2B Services and Data: Professional data services, authentication services (Vademecum Connect), and data partnerships with healthcare organizations and pharmaceutical companies

Pricing tiers

ModelBillingPrice
SubscriptionAnnualProfessional individual and institutional subscriptions for healthcare professionals

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Vidal Vademecum Spain product offering

Product offering

Core offering

Vidal Vademecum Spain publishes and operates Vademecum.es, a curated pharmaceutical reference platform providing drug information, active ingredients, ATC classifications, laboratory details, indications, international equivalences, CNIS drug information, therapeutic positioning reports, safety alerts, and supply-chain notices exclusively to qualified healthcare professionals in Spain. The platform also enables pharmaceutical companies to run regulatory-compliant advertising directed at those professionals, and offers authentication (Vademecum Connect) and education (Campus) as adjacent services.

Product overview

Vidal Vademecum Spain operates Vademecum.es, a comprehensive pharmaceutical reference database for healthcare professionals in Spain. The platform provides a unified system with multiple integrated modules including the core drug database (medications, active ingredients, ATC classifications, laboratories, clinical indications), CNIS drug information center, therapeutic positioning reports (IPT), safety information materials (MPR), the Campus educational platform, Vademecum Connect authentication service, and a newsletter (Boletín). The platform also includes specialized databases for supply issues (incidencias de suministro), safety alerts (alertas), and international equivalences. The offering is directed exclusively at healthcare professionals and is officially recognized by Spanish health authorities as a valid medium for prescription medication advertising.

Differentiator

Problem solved

Functional benefit

Brands

  • VADEMECUM CONNECT: Authentication solution allowing Vademecum account holders to log into third-party websites using their Vademecum credentials.
  • Campus

Products and services

  • Vademecum.es Core web platform providing a curated Spanish pharmaceutical drug reference covering medications, active pharmaceutical ingredients, ATC classifications, laboratories, clinical indications, international equivalences, AEMPS safety alerts, and supply-incident tracking. Exclusively for verified healthcare professionals.
  • Vademecum Box Professional tool providing streamlined access to Vademecum's pharmaceutical knowledge and medication information for prescribers and pharmacists.
  • Campus Medical education platform providing courses, webinars, and clinical training resources for healthcare professionals.
  • CNIS Drug Information Center Drug information center within Vademecum providing detailed medication data and therapeutic positioning reports (IPT) for healthcare professionals.
  • Listado IPT Curated collection of therapeutic positioning reports (Informes de Posicionamiento Terapéutico) authorized by AEMPS, providing pharmacological assessment documentation.
  • Listado MPR Listing of safety information materials (Materiales Informativos sobre Seguridad) about AEMPS-authorized medications, covering risk minimization materials for HCPs.
  • Vademecum Connect Federated identity / SSO service allowing healthcare professionals to securely access third-party partner healthcare websites using their existing Vademecum account credentials.
  • Boletín Newsletter service delivering pharmaceutical news, AEMPS drug alerts, supply updates, and clinical information to registered healthcare professionals.

Companies that use Vidal Vademecum Spain

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Vidal Vademecum Spain technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Vidal Vademecum Spain partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and supporting.

  • Pharmaceutical CompaniescoreStrategic or Co-development PartnerContent providers supplying medication information, product details, and promotional content. Pharmaceutical companies are responsible for the accuracy of their submitted information per pharmaceutical regulations.
  • Healthcare Professional PartnerscoreStrategic or Co-development PartnerPartners in sending non-promotional health information. Joint data controllers for communications to healthcare professionals about partner products and services.
  • Third-party Healthcare Websites (Vademecum Connect)supportingTechnology or IntegrationHealthcare websites implementing Vademecum Connect authentication allowing professionals to use their Vademecum credentials for access. User data transferred to third-party site operators as independent data controllers.
  • Third-party Advertising PartnerssupportingChannel Partner/ Reseller/ DistributorAdvertising partners using personalized advertising cookies and tracking technologies. Partners operate under IAB Transparency and Consent Framework 2.0 for consent management.
  • AEMPS (Spanish Agency of Medicines and Medical Devices)coreOthersOfficial regulatory body. Vademecum.es aggregates and distributes AEMPS alerts, safety notices, supply issue reports, and therapeutic positioning information for healthcare professionals.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Vidal Vademecum Spain competitors and assessment

Company assessment

Broad incumbents

  • Medscape (WebMD Health Corp.): Major professional medical information and education platform with pharma advertising and reference tools. Comparable in combining HCP drug reference, professional education, and pharma sponsorship, but operates at much larger scale and global scope.
  • M3, Inc. Ultimate parent company of Vidal Vademecum Spain, operating a global medical information, physician platform, and marketing services business (including MDLinx and m3.com). Comparable at the business model and category level (HCP drug information, pharma marketing) though far larger and diversified.
  • Wolters Kluwer Clinical Drug Information (Medi-Span / UpToDate Lexidrug): Large incumbent publisher of clinical drug information and decision support tools. Overlaps with Vademecum's professional drug reference and clinical decision support offering, but as part of a much broader portfolio.
  • Elsevier Clinical Solutions (ClinicalKey, PharmaPendium): Elsevier's clinical and drug information platforms serve HCPs with reference, drug, and regulatory content. Comparable in combining curated pharmaceutical content with professional subscription models, embedded in a large publishing incumbent.

Direct peers

  • Drugs.com: Online pharmaceutical reference providing drug information, interactions, and consumer/professional tools. Closely comparable as a multi-revenue (ads + data) drug information platform serving HCPs and consumers, though with a US/global orientation.
  • First Databank (FDB): Provider of drug knowledge and medication decision support used by EHRs, pharmacies, and HCPs. Comparable as a B2B drug information and data services company monetizing professional subscribers and enterprise integrations.
  • Vidal Vademecum France: Direct sister brand of Vidal Vademecum Spain under the same Vidal Group (controlled by M3, Inc.). Operates the same drug information reference platform model for healthcare professionals in France, making it the most structurally comparable peer.
  • IBM Micromedex: Clinical decision support and drug information solution used by hospitals and HCPs. Comparable as a paid, professional-grade drug reference and evidence database with subscription and enterprise models.

Regional players

  • CIMA (AEMPS - Centro de Información online de Medicamentos de la AEMPS): Official Spanish regulator's drug information portal. Comparable in covering Spanish-approved medicines, drug data, and IPTs, but as a free government-issued source that can substitute for parts of Vademecum's offering.
  • Bot Plus (Consejo General de Colegios Farmacéuticos): Official Spanish pharmacy drug database operated by the General Council of Pharmacists. Comparable as a Spanish HCP drug reference, but free and pharmacy-society-issued, representing a regulated substitute rather than a commercial competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Vidal Vademecum Spain social profiles

Digital presence

Vidal Vademecum Spain compliance and trust

Trust signal

Compliance2 records

Vidal Vademecum Spain financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vidal Vademecum Spain leadership team

Management profile

Number of profiles

Vidal Vademecum Spain funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vidal Vademecum Spain M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vidal Vademecum Spain

What does Vidal Vademecum Spain do?

Vidal Vademecum Spain publishes and operates Vademecum.es, a curated pharmaceutical reference platform providing drug information, active ingredients, ATC classifications, laboratory details, indications, international equivalences, CNIS drug information, therapeutic positioning reports, safety alerts, and supply-chain notices exclusively to qualified healthcare professionals in Spain. The platform also enables pharmaceutical companies to run regulatory-compliant advertising directed at those professionals, and offers authentication (Vademecum Connect) and education (Campus) as adjacent services.

Is Vidal Vademecum Spain a public or private company?

Vidal Vademecum Spain is a private company. It is classified as corporate owned and is currently operating.

When was Vidal Vademecum Spain founded?

Vidal Vademecum Spain was founded in 1992. It employs 11 to 50 people.

Where is Vidal Vademecum Spain based?

Vidal Vademecum Spain is headquartered in Madrid, Spain, in the Europe region.

How does Vidal Vademecum Spain make money?

Three revenue lines are on record. Professional Subscriptions are the primary driver. The others are pharmaceutical Advertising and B2B Services and Data.

Who are Vidal Vademecum Spain's main competitors?

Broad incumbents on record are Medscape (WebMD Health Corp.), M3, Inc., Wolters Kluwer Clinical Drug Information (Medi-Span / UpToDate Lexidrug) and Elsevier Clinical Solutions (ClinicalKey, PharmaPendium). Direct peers are Drugs.com, First Databank (FDB), Vidal Vademecum France and IBM Micromedex. Regional players are CIMA (AEMPS - Centro de Información online de Medicamentos de la AEMPS) and Bot Plus (Consejo General de Colegios Farmacéuticos).

Does Vidal Vademecum Spain have an API?

No public API is recorded for Vidal Vademecum Spain.

What industry is Vidal Vademecum Spain in?

Vidal Vademecum Spain's product category is Pharmaceutical reference / medical information publishing. Its primary akta.pro industry code is HLACAOAN, Regulatory Submissions & Clinical Content Management (eCTD/Publishing), with a secondary code of MPAJACAC, Compliance & Risk Intelligence Publishing (KYC/AML, ESG, Cyber, Privacy). Its NAICS code is 54.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales